Essential hypertension: new insights and controversies in treatment with diuretics.
D000584:Amiloride / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D003327:Coronary Disease / Q000139:chemically induced; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006947:Hyperkalemia / Q000139:chemically induced; D006973:Hypertension / Q000188:drug therapy*; D008077:Lipoproteins, LDL / Q000097:blood; D008274:Magnesium / Q000097:blood; D011188:Potassium / Q000097:blood; D011189:Potassium Chloride / Q000008:administration & dosage; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D000959:Antihypertensive Agents; D004232:Diuretics; D004338:Drug Combinations; D008077:Lipoproteins, LDL; D049993:Sodium Chloride Symporter Inhibitors; D014280:Triglycerides; D006852:Hydrochlorothiazide; C020743:hydrochlorothiazide-triamterene; D013148:Spironolactone; D011189:Potassium Chloride; D000584:Amiloride; D005665:Furosemide; D008274:Magnesium; D011188:Potassium; D014223:Triamterene